Nanosonics Limited (FRA:OQS)
Germany flag Germany · Delayed Price · Currency is EUR
2.320
-0.100 (-4.13%)
Last updated: Dec 5, 2025, 8:03 AM CET

Nanosonics Company Description

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.

The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies.

It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform.

Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Nanosonics Limited
Country Australia
Founded 2000
Industry Electromedical and Electrotherapeutic Apparatus
Employees 470
CEO Michael Kavanagh

Contact Details

Address:
Building A
Macquarie Park, 2113
Australia
Phone 61 2 8063 1600
Website nanosonics.com.au

Stock Details

Ticker Symbol OQS
Exchange Frankfurt Stock Exchange
Fiscal Year July - June
Reporting Currency AUD
SIC Code 3845

Key Executives

Name Position
Michael Kavanagh Chief Executive Officer
Jason Burriss Chief Financial Officer
Rod Lopez Chief Operating Officer